CIK: 1744573 - Address: C/o Revance Therapeutics, Inc., 7555 Gateway Blvd, Newark, CA 94560
6 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/19/19 20:58
3/18/19
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAllouche CyrilCAOPrincipaS-815.4800-76D
1/23/19 21:38
1/22/19
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAllouche CyrilCAOPrincipaS.d-1117.770-1-144D
1/4/19 21:33
1/3/19
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAllouche CyrilCAOPrincipaS-719.4800-94D
11/21/18 18:30
11/20/18
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAllouche CyrilCAOPrincipaS-1020.6600-114D
11/9/18 20:59
11/9/18
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAllouche CyrilCAOPrincipaS.d-5223.720-2-325D
7/6/18 21:17
7/6/18
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAllouche CyrilCAOPrincipaS-1128.3500-85D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact